NMD Pharma receives Orphan Drug Designation from FDA for
Philllllthy x Adidas NMD S1 Expected to Release This Year
NMD Pharma
NMD pulls in $40M from Jeito-led, Roche-backed syndicate, gaining financial muscle to crack myasthenia gravis market | Fierce Biotech
Following a compound from start to finish - Nordic Life Science – the leading Nordic life science news service
NMD Pharma Raises $39.7 Million to Advance Pipeline Targeting Rare Neuromuscular Disorders - Global Genes
NMD Pharma gets FDA orphan drug designation
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Management team — NMD Pharma
Board — NMD Pharma
NMD Pharma on Twitter: "We are thrilled to announce the opening of our new office in the US. We look forward to expanding the team across the Atlantic and be part of
Jeito Capital Becomes Key Investor in NMD Pharma as Part of a €35 Million New Financing | Business Wire
Philllllthy x Adidas NMD S1 Expected to Release This Year